Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to ...

Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with ...

Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced its participation in the ...

SB 3 is expected to receive final approval in the House on Thursday before returning to the Senate. Senate lawmakers will ...

Protagenic Therapeutics shares soared 240% Monday on its all-stock merger with Phytanix Bio. New Phytanix targets CNS ...

A new review warns healthcare professionals about the potential dermatological risks of cannabis use, from allergic reactions ...

A new study reveals that gut cannabinoid receptor 1 (CB1R ... studies revealed that CB1R activation in the gut epithelium triggers the ERK1/2 signalling pathway, which leads to the downregulation of ...

Dr. Tomáš Páleníček is a leading Czech proponent of the use of psychedelics in certain kinds of psychiatric treatment. Such ...

At Ward and Smith, we are closely monitoring these developments to help our clients with the potential impacts on their businesses. Below is ...

The controversial measure is one of the top priorities of the 2025 legislative session for Lt. Gov. Dan Patrick.

The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...

Dr. Tomáš Páleníček is a leading Czech proponent of the use of psychedelics in certain kinds of psychiatric treatment. Such research has history in this part of the world.